XML 14 R7.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Condensed Consolidated Statement of Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Total
Common stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Income (Loss)
Beginning Balance at Dec. 31, 2022 $ 88,941 $ 17 $ 206,916 $ (116,598) $ (1,394)
Beginning Balance, shares at Dec. 31, 2022   16,569,000      
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) (6,705)     (6,705)  
Other comprehensive income (loss), net of tax 445       445
Issuance of restricted stock, shares   14,000      
Stock options exercised 124   124    
Stock options exercised, shares   21,000      
Stock-based compensation 1,959   1,959    
Ending Balance at Mar. 31, 2023 84,764 $ 17 208,999 (123,303) (949)
Ending Balance, shares at Mar. 31, 2023   16,604,000      
Beginning Balance at Dec. 31, 2023 85,077 $ 18 220,185 (134,277) (849)
Beginning Balance, shares at Dec. 31, 2023   17,532,000      
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) 155     155  
Other comprehensive income (loss), net of tax (418)       (418)
Issuance of acquisition-related stock 38,050 $ 3 38,047    
Issuance of acquisition-related stock , Shares   3,450,000      
Issuance of restricted stock, shares   12,000      
Stock options exercised $ 1,257   1,257    
Stock options exercised, shares 170,919 171,000      
Stock-based compensation $ 1,105   1,105    
Ending Balance at Mar. 31, 2024 $ 125,226 $ 21 $ 260,594 $ (134,122) $ (1,267)
Ending Balance, shares at Mar. 31, 2024   21,165,000